IP Library Granted Patent US 7,192,732
Granted Patent B2
US 7,192,732 · App. 11/357,125 · Granted Mar 20, 2007

Regulation of human caspase-1-like protease

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,192,732
App. No.
11/357,125
Granted
Mar 20, 2007
Kind
B2
Abstract

Screening methods to identify candidate therapeutic agents using a newly identified human caspases-1-like protease.

Claims (6)

1. A method of screening for candidate therapeutic agents, comprising the steps of:

contacting a protein comprising the amino acid sequence shown in SEQ ID NO:6 with a test compound;

assaying for binding between the protein and the test compound; and

identifying a test compound that binds to the protein as a candidate therapeutic agent that may be useful for regulating activity of the protein.

2. The method of claim 1 wherein either the test compound or the protein comprises a detectable label.

3. The method of claim 1 wherein either the test compound or the protein is bound to a solid support.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 20, 2013
From: BAYER PHARMA AG
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 029839/0959 →
CHANGE OF NAME Recorded Oct 18, 2012
From: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
To: BAYER PHARMA AG
Reel/Frame 029150/0303 →
MERGER Recorded Feb 19, 2009
From: BAYER HEALTHCARE AG
To: BAYER SCHERING PHARMA AG
Reel/Frame 022277/0324 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 6, 2007
From: BAYER AKTIENGESELLSCHAFT
To: BAYER HEALTHCARE AG
Reel/Frame 018854/0774 →